HEADLINES International News

Oxford’s coronavirus vaccine AstraZeneca resumes trial

The AstraZeneca Oxford coronavirus vaccine trials have resumed on Saturday (September 12, 2020).

Over 18,000 individuals globally have reportedly received study vaccines as part of the trial.

Earlier on September 6, the standard review process triggered a voluntary pause to vaccination across all global trials to allow the review of safety data by independent committees and international regulators.

Share

Leave a Reply

Your email address will not be published. Required fields are marked *

Our YouTube ChannelOur Facebook PageOur Twitter PageOur LinkedIn PageOur Instagram PageOur Whatsapp NumberYour Idea